Description

4H-Pyrido[2,3-C]Pyrrolo[1,2-E][1,2,5]Triazepine,7-Ethyl-6,7-Dihydro-7-Methyl-(9Ci) is a high-purity, complex heterocyclic compound with the CAS number 708969-02-2, serving as a critical advanced intermediate in modern organic synthesis. This compound is valued for its intricate fused-ring structure, which makes it a versatile building block for constructing novel molecular architectures. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new active pharmaceutical ingredients (APIs) and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: Key precursor in the research and synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology therapeutic areas.
• Organic Synthesis Building Block: Used in complex multi-step syntheses to introduce the unique pyrido-pyrrolo-triazepine scaffold into target molecules.
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and library synthesis for high-throughput screening.
• Agrochemical Research: Potential intermediate in the development of new crop protection agents with novel modes of action.
• Material Science Exploration: Investigated as a potential component for creating organic electronic materials or specialty polymers.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for clients.

Basic Information

Product Name	4H-Pyrido[2,3-C]Pyrrolo[1,2-E][1,2,5]Triazepine,7-Ethyl-6,7-Dihydro-7-Methyl-(9Ci)
CAS No.	708969-02-2
Molecular Formula	C12H14N4
Molecular Weight	214.27 g/mol
Synonyms	7-Ethyl-6,7-dihydro-7-methyl-4H-pyrido[2,3-c]pyrrolo[1,2-e][1,2,5]triazepine; 4H-Pyrido[2,3-c]pyrrolo[1,2-e][1,2,5]triazepine, 7-ethyl-6,7-dihydro-7-methyl- (9CI); 708969-02-2; 7-Ethyl-7-methyl-6,7-dihydro-4H-pyrido[2,3-c]pyrrolo[1,2-e][1,2,5]triazepine
EINECS	Contact for details

Quality Control

Every batch of this advanced intermediate is produced and analyzed under strict quality management protocols. We provide comprehensive Certificates of Analysis (COA) that detail purity, identity, and impurity profiles, ensuring traceability and consistency for your critical research and development projects. Our quality systems are designed to support cGMP compliance for pharmaceutical applications, with documentation ready for regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The container should be kept tightly sealed in a dry environment to minimize moisture uptake and exposure to air.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Any single unknown impurity	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.